Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

Journal of Experimental Medicine

Volumn 205, Issue 13, 2008, Pages 3119-3131

  Gaucher, Denis ^a   Therrien, René ^a   Kettaf, Nadia ^a   Angermann, Bastian R ^a   Boucher, Geneviéve ^a   Filali Mouhim, Abdelali ^a   Moser, Janice M ^b   Mehta, Riyaz S ^b   Drake III, Donald R ^b   Castro, Erika ^c,d   Akondy, Rama ^e   Rinfret, Aline ^f,g   Yassine Diab, Bader ^a   Said, Elias A ^a   Chouikh, Younes ^a   Cameron, Mark J ^h   Clum, Robert ^h   Kelvin, David ^h   Somogyi, Roland ⁱ   Greller, Larry D ⁱ   Balderas, Robert S ^j   Wilkinson, Peter ^a   Pantaleo, Giuseppe ^c   Tartaglia, Jim ^k   Haddad, Elias K ^a,l   Sekaly, Rafick Pierre ^a,b,l   more..

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b VaxDesign Corporation   (United States)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Canadian Network for Vaccines and Immunotherapeutics   (Canada)

^g HEALTH CANADA   (Canada)

^h UNIVERSITY HEALTH NETWORK   (Canada)

ⁱ Biosystemix Ltd   (Canada)

^j BD BIOSCIENCES   (United States)

^k Aventis Pasteur Ltd   (Canada)

^l MCGILL UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; RNA; TUMOR NECROSIS FACTOR; YELLOW FEVER VACCINE; INTERLEUKIN 1BETA;

ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; COHORT ANALYSIS; CYTOKINE RELEASE; EFFECTOR CELL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE DRUG DOSE; T LYMPHOCYTE ACTIVATION; VACCINATION; YELLOW FEVER; B LYMPHOCYTE; CYTOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; IMMUNITY; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE SUBPOPULATION; PHYSIOLOGY; T LYMPHOCYTE;

B-LYMPHOCYTES; CELL PROLIFERATION; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; IMMUNE SYSTEM PROCESSES; IMMUNITY, INNATE; INTERLEUKIN-1BETA; LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; VACCINATION; YELLOW FEVER VACCINE;

EID: 59649129816     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20082292     Document Type: Article

References (62)

1. Sekaly, R.P. 2008. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?J. Exp. Med. 205:7-12.
2. Plotkin, S., and W. Orenstein. 2004. Vaccines. WB Saunders, Philadelphia. 3. McMichael, A.J. 2006. HIV vaccines. Annu. Rev. Immunol. 24:227-255.
3. Monath, T.P. 2004. Yellow fever vaccine. In Vaccines. S. Plotkin and W. Orenstein, editors. WB Saunders, Philadelphia. 1095-1176.
4. Bauer, J .H. 1931. The duration of passive immunity in yellow fever. Am. J. Trop. Med. Hyg. 11:451.
5. Brandriss, M.W., J .J. Schlesinger, E.E. Walsh, and M. Briselli. 1986. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.J. Gen. Virol. 67(Pt 2):229-234.
6. Reinhardt, B., R. Jaspert, M. Niedrig, C. Kostner, and J. L'Age-Stehr. 1998. Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection. J. Med. Virol. 56:159-167.
7. Santos, A.P., A.L. Bertho, D.C. Dias, J.R. Santos, and R. Marcovistz. 2005. Lymphocyte subset analyses in healthy adults vaccinated with yellow fever 17DD virus. Mem. Inst. Oswaldo Cruz. 100:331-337.
8. Co, M.D., M. Terajima, J. Cruz, F.A. Ennis, and A.L. Rothman. 2002. Human cytotoxic T lymphocyte responses to live attenuated 17D yel- low fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. Virology. 293:151-163.
9. Miller, J.D., R.G. van der Most, R.S. Akondy, J.T. Glidewell, S. Albott, D. Masopust, K. Murali-Krishna, P.L. Mahar, S. Edupuganti, S. Lalor, et al. 2008. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity. 28:710-722.
10. Xie, X., J. Lu, E.J. Kulbokas, T.R. Golub, V. Mootha, K. Lindblad-Toh, E.S. Lander, and M. Kellis. 2005. Systematic discovery of regulatory motifs in human promoters and 3 ' UTRs by comparison of several mammals. Nature. 434:338-345.
11. Monaco, J.J., S. Cho, and M. Attaya. 1990. Transport protein genes in the murine MHC: possible implications for antigen processing. Science. 250:1723-1726.
12. Trowsdale, J ., I . Hanson, I. Mockridge, S. Beck, A. Townsend, and A. Kelly. 1990. Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters. Nature. 348:741-744.
13. Nicholson, S.E., and D.J. Hilton. 1998. The SOCS proteins: a new family of negative regulators of signal transduction. J. Leukoc. Biol. 63:665-668.
14. Scherer, C.A., C.L. Magness, K.V. Steiger, N.D. Poitinger, C.M. Caputo, D.G. Miner, P.L. Winokur, D. Klinzman, J. McKee, C. Pilar, et al. 2007. Distinct gene expression profiles in peripheral blood mono-nuclear cells from patients infected with vaccinia virus, yellow fever 17D virus, or upper respiratory infections. Vaccine. 25:6458-6473.
15. Martinon, F., K. Burns, and J . Tschopp. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell. 10:417-426.
16. + T cells with diverse cytokine profiles. Nat. Med. 11:1113-1117.
17. + T cells specific for defined antigens according to CD154 expression. Nat. Med. 11:1118-1124.
18. + central memory T cells. J. Exp. Med. 200:725-735.
19. Poland, J.D., C.H. Calisher, T.P. Monath, W.G. Downs, and K. Murphy. 1981. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bull. World Health Organ. 59:895-900.
20. Colina, R., M. Costa-Mattioli, R.J. Dowling, M. Jaramillo, L.H. Tai, C.J. Breitbach, Y. Martineau, O. Larsson, L. Rong, Y.V. Svitkin, et al. 2008. Translational control of the innate immune response through IRF-7. Nature. 452:323-328.
21. Honda, K., H. Yanai, H. Negishi, M. Asagiri, M. Sato, T. Mizutani, N. Shimada, Y. Ohba, A. Takaoka, N. Yoshida, and T. Taniguchi. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature. 434:772-777.
22. Querec, T., S. Bennouna, S. Alkan, Y. Laouar, K. Gorden, R. Flavell, S. Akira, R. Ahmed, and B. Pulendran. 2006. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 203:413-424.
23. Kawai, T., and S. Akira. 2006. TLR signaling. Cell Death Differ. 13:816-825.
24. Gallant, S., and G. Gilkeson. 2006. ETS transcription factors and regulation of immunity. Arch. Immunol. Ther. Exp. (Warsz.). 54:149-163.
25. Bhat, N.K., C.B. Thompson, T. Lindsten, C.H. June, S. Fujiwara, S. Koizumi, R.J. Fisher, and T.S. Papas. 1990. Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1. Proc. Natl. Acad. Sci. USA. 87:3723-3727.
26. Sun, H.J., X. Xu, X.L. Wang, L. Wei, F. Li, J. Lu, and B.Q. Huang. 2006. Transcription factors Ets2 and Sp1 act synergistically with histone acetyltransferase p300 in activating human interleukin-12 p40 promoter. Acta Biochim. Biophys. Sin. (Shanghai). 38:194-200.
27. Blumenthal, S.G., G. Aichele, T. Wirth, A.P. Czernilofsky, A. Nordheim, and J . Dittmer. 1999. Regulation of the human interleu- kin-5 promoter by Ets transcription factors. Ets1 and Ets2, but not Elf-1, cooperate with GATA3 and HTLV-I Taxi. J. Biol. Chem. 274:12910-12916.
28. Koizumi, H., M.F. Horta, B.S. Youn, K.C. Fu, B.S. Kwon, J.D. Young, and C.C. Liu. 1993. Identification of a killer cell-specific regulatory element of the mouse perforin gene: an Ets-binding site-homologous motif that interacts with Ets-related proteins. Mol. Cell. Biol. 13:6690-6701.
29. Harada, H., T. Taniguchi, and N. Tanaka. 1998. The role of inter-feron regulatory factors in the interferon system and cell growth control. Biochimie. 80:641-650.
30. Masumi, A., S. Tamaoki, I.M. Wang, K. Ozato, and K. Komuro. 2002. IRF-8/ICSBP and IRF-1 cooperatively stimulate mouse IL-12 promoter activity in macrophages. FEBS Lett. 531:348-353.
31. Wang, I.M., C. Contursi, A. Masumi, X. Ma, G. Trinchieri, and K. Ozato. 2000. An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages. J. Immunol. 165:271-279.
32. Liu, J., X. Guan, T. Tamura, K. Ozato, and X. Ma. 2004. Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein. J. Biol. Chem. 279:55609-55617.
33. Tsujimura, H., T. Tamura, H.J. Kong, A. Nishiyama, K.J. Ishii, D.M. Klinman, and K. Ozato. 2004. Toll-like receptor 9 signaling activates NF-kappaB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells. J. Immunol. 172:6820-6827.
34. Lee, C.H., M. Melchers, H. Wang, T.A. Torrey, R. Slota, C.F. Qi, J.Y. Kim, P. Lugar, H.J. Kong, L. Farrington, et al. 2006. Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein. J. Exp. Med. 203:63-72.
35. Natkunam, Y., S. Zhao, D.Y. Mason, J. Chen, B. Taidi, M. Jones, A.S. Hammer, S. Hamilton Dutoit, I .S. Lossos, and R. Levy. 2007. The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. Blood. 109:1636-1642.
36. Hansson, A., C. Manetopoulos, J .I. J onsson, and H. Axelson. 2003. The basic helix-loop-helix transcription factor TAL1/SCL inhibits the expression of the p16INK4A and pTalpha genes. Biochem. Biophys. Res. Commun. 312:1073-1081.
37. Sardet, C., M. Vidal, D. Cobrinik, Y. Geng, C. Onufryk, A. Chen, and R.A. Weinberg. 1995. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA. 92:2403-2407.
38. +) T cells during HIV infection. Nat. Med. 14:266-274.
39. Furukawa, Y., N. Nishimura, M. Satoh, H. Endo, S. Iwase, H. Yamada, M. Matsuda, Y. Kano, and M. Nakamura. 2002. Apaf-1 is a mediator of E2F-1-induced apoptosis. J. Biol. Chem. 277:39760-39768.
40. Petrilli, V., C. Dostert, D.A. Muruve, and J. Tschopp. 2007. The in-flammasome: a danger sensing complex triggering innate immunity. Curr. Opin. Immunol. 19:615-622.
41. Muruve, D.A., V. Petrilli, A.K. Zaiss, L.R. White, S.A. Clark, P.J. Ross, R.J. Parks, and J. Tschopp. 2008. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature. 452:103-108.
42. Li, H., S.B. Willingham, J.P. Ting, and F. Re. 2008. Cutting edge: in-flammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J. Immunol. 181:17-21.
43. Martinon, F., and J. Tschopp. 2004. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell. 117:561-574.
44. Mantovani, A., M. Locati, A. Vecchi, S. Sozzani, and P. Allavena. 2001. Decoy receptors: a strategy to regulate inflammatory cytokines and che- mokines. Trends Immunol. 22:328-336.
45. Wan, L., C.W. Lin, Y.J. Lin, J.J. Sheu, B.H. Chen, C.C. Liao, Y. Tsai, W.Y. Lin, C.H. Lai, and F.J. Tsai. 2008. Type I IFN induced IL1-Ra expression in hepatocytes is mediated by activating STAT6 through the formation of STAT2: STAT6 heterodimer. J. Cell. Mol. Med. 12:876-878.
46. Gabay, C., M. Dreyer, N. Pellegrinelli, R. Chicheportiche, and C.A. Meier. 2001. Leptin directly induces the secretion of interleukin 1 receptor antagonist in human monocytes. J. Clin. Endocrinol. Metab. 86:783-791.
47. Stanley, S.L. J r., S.E. Frey, P. Taillon-Miller, J . Guo, R.D. Miller, D.C. Koboldt, M. Elashoff, R. Christensen, N.L. Saccone, and R.B. Belshe. 2007. The immunogenetics of smallpox vaccination. J. Infect. Dis. 196:212-219.
48. Csomor, E., Z. Bajtay, N. Sandor, K. Kristof, G.J. Arlaud, S. Thiel, and A. Erdei. 2007. Complement protein C1q induces maturation of human dendritic cells. Mol. Immunol. 44:3389-3397.
49. Mehlhop, E., and M.S. Diamond. 2006. Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J. Exp. Med. 203:1371-1381.
50. Mehlhop, E., K. Whitby, T. Oliphant, A. Marri, M. Engle, and M.S. Diamond. 2005. Complement activation is required for induction of a protective antibody response against West Nile virus infection. J. Virol. 79:7466-7477.
51. Santos, A.P., D.C. Matos, A.L. Bertho, S.C. Mendonca, and R. Marcovistz. 2008. Detection of Th1/Th2 cytokine signatures in yellow fever 17DD first-time vaccinees through ELISpot assay. Cytokine. 42:152-155.
52. Brunner, C., A. Sindrilaru, I. Girkontaite, K.D. Fischer, C. Sunderkotter, and T. Wirth. 2007. BOB.1/OBF.1 controls the balance of TH1 and TH2 immune responses. EMBO J. 26:3191-3202.
53. Wang, Y., and R.H. Carter. 2005. CD19 regulates B cell maturation, proliferation, and positive selection in the FDC zone of murine splenic germinal centers. Immunity. 22:749-761.
54. Steinman, R.M., and J. Banchereau. 2007. Taking dendritic cells into medicine. Nature. 449:419-426.
55. Redecke, V., H. Hacker, S.K. Datta, A. Fermin, P.M. Pitha, D.H. Broide, and E. Raz. 2004. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J. Immunol. 172:2739-2743.
56. Gorden, K.B., K.S. Gorski, S.J. Gibson, R.M. Kedl, W.C. Kieper, X. Qiu, M.A. Tomai, S.S. Alkan, and J.P. Vasilakos. 2005. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J. Immunol. 174:1259-1268.
57. Van Gelder, R.N., M.E. von Zastrow, A. Yool, W.C. Dement, J .D. Barchas, and J.H. Eberwine. 1990. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc. Natl. Acad. Sci. USA. 87:1663-1667.
58. Gentleman, R.C., V.J. Carey, D.M. Bates, B. Bolstad, M. Dettling, S. Dudoit, B. Ellis, L. Gautier, Y. Ge, J. Gentry, et al. 2004. Bioconductor: open software development for computational biology and bioinformat- ics. Genome Biol. 5:R80. 60. Smyth, G.K. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3.
59. Smith, G.K. 2005. Limma: linear models for microarray data. In Bioinformatics and Computational Biology Solutions using R and Bioconductor. W. Huber, editor. Springer, New York. 397-420.
60. Baron, C., R. Somogyi, L.D. Greller, V. Rineau, P. Wilkinson, C.R. Cho, M.J. Cameron, D.J. Kelvin, P. Chagnon, D.C. Roy, et al. 2007. Prediction of graft-versus-host disease in humans by donor gene-expression rofiling. PLoS Med. 4:e23.
61. Teschendorff, A.E., M. Journee, P.A. Absil, R. Sepulchre, and C. Caldas. 2007. Elucidating the altered transcriptional programs in breast cancer using independent component analysis. PLoS Comput Biol. 3:e161.
62. Younes, S.A., B. Yassine-Diab, A.R. Dumont, M.R. Boulassel, Z. Grossman, J .P. Routy, and R.P. Sekaly. 2003. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J. Exp. Med. 198:1909-1922.